Article
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
medRxiv · 2023 · Catherine N. Russell, author Jennifer L. Carter, author Juliet M. Borgia, author Jacob Bush, author Félix Calderón, author Raquel Gabarró, author Stuart J. Conway, author Jeremy C. Mottram, author Anthony J. Wilkinson, author Nathaniel G. Jones, author
Key facts
| Title | Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery |
|---|---|
| First author | Catherine N. Russell, author Jennifer L. Carter, author Juliet M. Borgia, author Jacob Bush, author Félix Calderón, author Raquel Gabarró, author Stuart J. Conway, author Jeremy C. Mottram, author Anthony J. Wilkinson, author Nathaniel G. Jones, author |
| Journal | medRxiv |
| Published | Aug 30, 2023 |
| DOI | 10.1101/2023.08.21.554125 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIE, KIT, NDS, NJT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1